Cost of cancer care varies widely based on who pays the bill
the ONA take:
Cost disparities in chemotherapy drugs can be substantial, reveals a new study from the University of North Carolina and Chapel Hill.
Researchers found uninsured patients with cancer are asked to pay on average 2 times more than Medicare recipients would pay for the same drugs, and that difference can go as high as 43 times more. The uninsured even pay more than those with private insurance.
Cost of doctor visits for cancer patients was also reviewed, and the same discrepancy in costs was seen. For example, uninsured patients were billed $129 to $391, depending on the complexity of the visit; however, Medicare and private insurance paid $65 to $188 and $78 to $246, respectively, for the same visits.
Researchers report that patients with Medicare or private insurance are paying a discounted rate for their health care. Uninsured patients do not have the bargaining power, or may not try to negotiate price on their own.
Uninsured patients with cancer are asked to pay on average 2 times more than Medicare recipients would pay for the same drugs
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Endocrine Society Released Guidelines for Managing Endocrine Disorders in Childhood Cancer Survivors
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|